Indapta Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Indapta Therapeutics's estimated annual revenue is currently $4.5M per year.
- Indapta Therapeutics's estimated revenue per employee is $155,000
- Indapta Therapeutics's total funding is $112M.
Employee Data
- Indapta Therapeutics has 29 Employees.
- Indapta Therapeutics grew their employee count by 12% last year.
Indapta Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer and Founder | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Acting Chief Medical Officer | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | VP Research and Development | Reveal Email/Phone |
7 | VP Research | Reveal Email/Phone |
8 | Head Regulatory & Quality | Reveal Email/Phone |
9 | Sr. Director, CMC Project Management | Reveal Email/Phone |
10 | Senior Research Associate | Reveal Email/Phone |
Indapta Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $9.1M | 59 | -9% | N/A | N/A |
#10 | $16.6M | 107 | 3% | N/A | N/A |
What Is Indapta Therapeutics?
Indapta's allogeneic g-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
keywords:N/A
$112M
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator